D-0599-2025 Class II Terminated

Recalled by Lannett Company Inc. — Seymour, IN

FDA drug recall D-0599-2025 was initiated by Lannett Company Inc. on Aug 11, 2025 and is designated Class II. Reason for recall: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg. The recall status is terminated (terminated Jun 24, 2026). Affected quantity: 8544 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 3, 2025
Initiation Date
Aug 11, 2025
Termination Date
Jun 24, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8544 bottles

Product description

Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37

Reason for recall

Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Distribution pattern

Nationwide within the USA

Code information

Lot #: 25280726A, Exp. Date 03/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0599-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0599-2025. Report a data issue: hello@regdatalab.com.